PARP Inhibitor Olaparib Use in a BRCA1-Positive Patient...

PARP Inhibitor Olaparib Use in a BRCA1-Positive Patient With Metastatic Triple-Negative Breast Cancer, Without the Initial Use of Platinum-Based Chemotherapy, Showing Significant Rapid Near Resolution of Large Liver Metastasis While Patient Experienced Gout-Like Symptoms

Matthews Hew, Trevanne, Zuberi, Lara
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
7
Language:
english
Journal:
Journal of Investigative Medicine High Impact Case Reports
DOI:
10.1177/2324709619864989
Date:
January, 2019
File:
PDF, 454 KB
english, 2019
Conversion to is in progress
Conversion to is failed